All stock lists
Hennessy Capital Investment Cor (NASDAQ:HVII)
US · Delayed Price · Currency is USD
Financial Services · Shell Companies
$4.46-$4.62 (-50.88%)
Market cap
$87.8M
Insider Score
Health Score
Listed since
Jan 17, 2025
Website
Insider Score
––Not scored
HVII Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Weak
From HVII’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$72973.50B
- Net margin
- —
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $1495.64B
- Total debt
- $0
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $2221.51B
- Current liabilities
- $64899.39B
- Current ratio
- 0.03
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$338K
- Free cash flow
- -$338K
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 95.5M
- Share growth (1y)
- 402.4%
- Cash runway
- 53153620 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
HVII Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expense | $12782.28 B | $771.07 K | $1.10 M | $1.90 M | $819.22 K | $448.91 K |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $12782.28 B | $771.07 K | $1.10 M | $1.90 M | $819.22 K | $448.91 K |
| Operating Income | -$12782.28 B | -$771.07 K | -$1.10 M | -$1.90 M | -$819.22 K | -$448.91 K |
| Pretax Income | -$72973.50 B | $915.12 K | $575.61 K | -$42.90 K | $1.19 M | $1.52 M |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$72973.50 B | $915.12 K | $575.61 K | -$42.90 K | $1.19 M | $1.52 M |
| EPS (Basic) | -$0.76 | $0.04 | $0.02 | -$0.00 | $0.05 | $0.06 |
| EPS (Diluted) | -$0.76 | $0.04 | $0.02 | -$0.00 | $0.05 | $0.06 |
| Shares Outstanding | 95.46 M | 19.00 M | 19.00 M | 17.91 M | 19.00 M | 26.02 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
